Kenneth Kovan
Förmögenhet: 102 881 $ per 2026-07-31
Förmögenhet: 102 881 $ per 2026-07-31
Kenneth E.
Kovan is the founder of AVAX Technologies, Inc., founded in 1990.
Mr. Kovan is the founder of Bingham Hill Ventures, founded in 2012, holding the title of Managing Principal.
Mr. Kovan is also the founder of BioVaxys Technology Corp.,BioVaxys LLC.
Mr. Kovan is currently the President of Chaperone Technologies, Inc. Former positions include Principal at Thomas Jefferson University, Principal at GSK Plc, Principal at Wyeth-Ayerst Research, and Partner at Revvity Discovery Ltd.
| Företag | Datum | Antal aktier | Värdering | Värderingsdatum |
|---|---|---|---|---|
BIOVAXYS TECHNOLOGY CORP 3,21 % | 2025-10-20 | 935 286 ( 3,21 % ) | 102 881 $ | 2026-07-31 |
| Företag | Position | Start |
|---|---|---|
| BIOVAXYS TECHNOLOGY CORP. | Grundare | - |
Chaperone Technologies, Inc.
Chaperone Technologies, Inc. Medical SpecialtiesHealth Technology Develops novel products for infectious diseases | President | - |
BioVaxys LLC
BioVaxys LLC BiotechnologyHealth Technology Develops viral oncology and therapeutic platforms | Grundare | - |
Bingham Hill Ventures | Grundare | 2012-01-01 |
| Företag | Position | Slut |
|---|---|---|
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and supplying patient-relevant drug discovery and diagnostic research tools | Företagsledare/Principal | - |
Wyeth-Ayerst Research | Företagsledare/Principal | - |
| GSK PLC | Företagsledare/Principal | - |
Thomas Jefferson University
Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Företagsledare/Principal | - |
| AVAX TECHNOLOGIES, INC. | Grundare | - |
Aktiva
Inaktiva
Börsnoterade företag
Privata företag
Första gradens relationer
Företag kopplade till första graden
Man
Kvinna
Styrelseledamöter
Chefer
| Privata företag | 9 |
|---|---|
AVAX Technologies, Inc.
AVAX Technologies, Inc. BiotechnologyHealth Technology Operates as development stage company with interest in the development and future commercialization of individualized cancer vaccines | Health Technology |
Thomas Jefferson University
Thomas Jefferson University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
GSK Plc
GSK Plc Pharmaceuticals: MajorHealth Technology Develops, manufactures and distributes vaccines and other pharmaceutical products | Health Technology |
Wyeth-Ayerst Research | |
Chaperone Technologies, Inc.
Chaperone Technologies, Inc. Medical SpecialtiesHealth Technology Develops novel products for infectious diseases | Health Technology |
Horizon Discovery Ltd.
Horizon Discovery Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and supplying patient-relevant drug discovery and diagnostic research tools | Commercial Services |
BioVaxys Technology Corp.
BioVaxys Technology Corp. Other Metals/MineralsNon-Energy Minerals Provides mining exploration services | Non-Energy Minerals |
BioVaxys LLC
BioVaxys LLC BiotechnologyHealth Technology Develops viral oncology and therapeutic platforms | Health Technology |
Bingham Hill Ventures |
Välj din utgåva
All finansiell information anpassad till den nationella nivån